Commonwealth Fusion Systems

Global Nuclear Fusion Technologies Market Expected to Skyrocket to $6.8 Billion by 2040, Driven by Technological Advancements and Private Investment

Retrieved on: 
Thursday, November 9, 2023
Commonwealth Fusion Systems, Nuclear fusion, TAE Technologies, Education minister, TAE, Growth, Renewable energy, Lithium, 3D printing

The global nuclear fusion technologies market is poised for remarkable growth, with projections indicating a surge from $1.7 billion in 2035 to a staggering $6.8 billion by the end of 2040.

Key Points: 
  • The global nuclear fusion technologies market is poised for remarkable growth, with projections indicating a surge from $1.7 billion in 2035 to a staggering $6.8 billion by the end of 2040.
  • This substantial growth is expected to be driven by advancements in fusion technology, increasing private investment, and a growing number of innovative start-ups entering the nuclear fusion industry.
  • Global Growth: The global nuclear fusion technologies market is forecasted to achieve a compound annual growth rate (CAGR) of 31.6% during the period of 2035-2040, reflecting the rapid evolution of fusion technology.
  • The "Global Nuclear Fusion Technologies Market Outlook 2035-2040" report provides comprehensive insights into the nuclear fusion market, including market trends, technological advances, regulatory landscapes, government-funded projects, and profiles of key industry players such as Commonwealth Fusion Systems, First Light Fusion Ltd, General Fusion Inc., HB11 Energy Holdings Pty Ltd, and Marvel Fusion GmbH.

Surge in Nuclear Fusion Start-Ups and Private Investment Signals a Promising Future for Clean Energy Generation - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 9, 2023
Nuclear, Energy, Other Energy, TAE, Commonwealth Fusion Systems, Nuclear fusion, Eni, Growth, Education minister, TAE Technologies, Lithium, 3D printing

This substantial growth is expected to be driven by advancements in fusion technology, increasing private investment, and a growing number of innovative start-ups entering the nuclear fusion industry.

Key Points: 
  • This substantial growth is expected to be driven by advancements in fusion technology, increasing private investment, and a growing number of innovative start-ups entering the nuclear fusion industry.
  • Furthermore, the nuclear fusion industry is witnessing a surge in start-ups exploring various fusion technologies, including magnetic confinement, inertial confinement, and hybrids.
  • Many of these start-ups have secured backing from prominent publicly listed companies, further emphasizing the growing interest and investment in nuclear fusion.
  • As nuclear fusion continues to make strides in becoming a prominent source of clean energy, the future of the global energy landscape looks promising, with the potential to revolutionize the way we generate power.

MIT Technology Review releases inaugural list of "15 Climate Tech Companies to Watch"

Retrieved on: 
Wednesday, October 4, 2023
Taste, Blue Frontier Campaign, EV, Climate, Metal, Atmosphere, Magnesium, System, GEM, Form Energy, Aviation, Electricity, NuScale Power, BYD, Carbon, Electronic waste, Wind, Electrochemistry, MIT Technology Review, EVS, Commonwealth Fusion Systems, Steam, Climate change, Climeworks, Atmosphere of Earth, Iron, Nickel, Water, Geothermal energy, Transport, Cobalt, Blue Frontier, CO2, Nuclear power plant, Farm, Renewable energy, Lithium

CAMBRIDGE, Mass., Oct. 4, 2023 /PRNewswire/ -- MIT Technology Review announces 15 Climate Tech Companies to Watch, a new annual list highlighting start-ups and established businesses that have the greatest potential to substantially reduce greenhouse-gas emissions or otherwise address the threats of global warming. The list is now available at TechnologyReview.com and was revealed live in a session led by MIT Technology Review's editor-in-chief, Mat Honan, and Casey Crownhart, climate reporter at the ClimateTech conference.

Key Points: 
  • MIT Technology Review reveals the list live at its annual sustainability conference, ClimateTech
    CAMBRIDGE, Mass., Oct. 4, 2023 /PRNewswire/ -- MIT Technology Review announces 15 Climate Tech Companies to Watch, a new annual list highlighting start-ups and established businesses that have the greatest potential to substantially reduce greenhouse-gas emissions or otherwise address the threats of global warming.
  • The list is now available at TechnologyReview.com and was revealed live in a session led by MIT Technology Review's editor-in-chief, Mat Honan, and Casey Crownhart, climate reporter at the ClimateTech conference.
  • The 15 Climate Tech Companies to Watch are:
    Blue Frontier : It's getting hot out there and will only get hotter, which means millions more people will need access to air conditioning just to survive.
  • For more information on the 15 Climate Tech Companies to Watch, visit MIT Technology Review's website at TechnologyReview.com .

Ascend Elements to Relocate and Expand Corporate Headquarters and R&D Tech Center to Devens, Massachusetts

Retrieved on: 
Wednesday, September 20, 2023
Hydrogen, Hydro, Worcester Polytechnic Institute, King Street Station, Research, System, Fort Smith to Jackson Road-Talbert's Ferry Segments, CAM, King Street, Recycling, Commonwealth Fusion Systems, Honda, Growth, Health, Environment, Lithium, United States Department of Energy, Greater Boston

WESTBOROUGH, Mass., Sept. 20, 2023 /PRNewswire/ -- Ascend Elements today announced plans to move its corporate headquarters and research & development center from its current location in Westborough, Mass. to a 101,000 square foot facility at 39 Jackson Road in the Pathway Devens campus in Devens, Mass. The facility is owned and operated by King Street Properties in Boston. Ascend Elements has experienced over 500% headcount growth in the last 18 months and currently employs approximately 350 team members globally, including 140 people in Massachusetts. The 31-mile relocation is planned for September 2024.

Key Points: 
  • WESTBOROUGH, Mass., Sept. 20, 2023 /PRNewswire/ -- Ascend Elements today announced plans to move its corporate headquarters and research & development center from its current location in Westborough, Mass.
  • Ascend Elements has experienced over 500% headcount growth in the last 18 months and currently employs approximately 350 team members globally, including 140 people in Massachusetts.
  • "This relocation will be a milestone for Ascend Elements as we continue our rapid growth in the engineered battery materials industry," said Mike O'Kronley, CEO of Ascend Elements.
  • We look forward to having space to expand and a facility that will meet our current and future needs."

Biomea Fusion Reports Second Quarter 2023 Financial Results and Corporate Highlights

Retrieved on: 
Monday, July 31, 2023
Momentum, CLL, PDAC, KRAS, Insulin, Food, American Diabetes Association, CRC, Diabetes, Investment, Chronic lymphocytic leukemia, ALL, Week, Menin, DLBCL, Multiple myeloma, NPM1, CD135, Bone marrow, OGTT, Type 2 diabetes, Mutation, G&A, NSCLC, B-cell lymphoma, QT interval, NUP98, AML, Hypoglycemia, HIV disease progression rates, Patient, DSM-IV codes, C-peptide, Administration, Cancer, MM, FLT3, CRS, Research and development, Commonwealth Fusion Systems, Research, R, ADA, IND, Disease, Pharmaceutical industry, Silviculture, Fine chemical, Vaccine, Medical imaging, Cryptocurrency, Glycated hemoglobin, Osteopathic medicine in Canada

Our goal at Biomea is to develop a treatment that can halt or reverse disease progression in patients with type 1 and type 2 diabetes.

Key Points: 
  • Our goal at Biomea is to develop a treatment that can halt or reverse disease progression in patients with type 1 and type 2 diabetes.
  • We look forward to continuing to evaluate BMF-219’s proposed mechanism of action and its potential therapeutic impact as this study progresses.
  • BMF-500 is an investigational oral covalent inhibitor of FLT3, designed and developed in-house, and the second investigational compound discovered by Biomea’s FUSION™ System.
  • G&A expenses were $11.4 million for the six months ended June 30, 2023 compared to $9.9 million for the same period in 2022.

Commonwealth Fusion Systems Selected by U.S. DOE for Milestone Program to Accelerate Commercial Fusion Energy

Retrieved on: 
Wednesday, May 31, 2023
Hardware, Oil, Gas, Building Systems, Alternative Energy, Construction & Property, Energy, Green Technology, Manufacturing, Technology, Nuclear, Environment, Other Technology, Other Manufacturing, Science, Other Science, CHIPS, U.S. Department of Energy, Office of Inspector General, Orbital, Private sector, U.S. Department of Defense Strategy for Operating in Cyberspace, SPARC, EJ, University, Fusion, ARC, Green Energy Act, 2009, History, DOE, CHIPS and Science Act, Commonwealth Fusion Systems, Congress, Plasma, NASA, Spaceflight, Physics, SpaceX, CFS, Commercial Orbital Transportation Services, COTS, Pharmaceutical industry, Lithium

Commonwealth Fusion Systems (CFS) has been selected by the U.S. Department of Energy (DOE) as an awardee in its $46 million milestone-based commercial fusion energy development program, a program designed to solidify U.S. leadership in commercial fusion energy.

Key Points: 
  • Commonwealth Fusion Systems (CFS) has been selected by the U.S. Department of Energy (DOE) as an awardee in its $46 million milestone-based commercial fusion energy development program, a program designed to solidify U.S. leadership in commercial fusion energy.
  • CFS is among one of eight companies to be selected and the only one pursuing the conventional tokamak approach to commercial fusion.
  • “CFS is honored to be selected for the DOE’s milestone-based fusion development program,” said Bob Mumgaard, CFS CEO and co-founder.
  • “This program is part of the bold commitment from the Biden-Harris Administration to bring clean fusion energy to the grid within the next decade.

Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change

Retrieved on: 
Tuesday, May 23, 2023
Wyss Institute for Biologically Inspired Engineering, Plastic, Collaborative Fund, Bakalar, Food, North American Vascular Biology Organization, Dandelion Energy, Partnership, Education, Research, Harvard University, Innovation system, Innovation, Harvard John A. Paulson School of Engineering and Applied Sciences, Modern Meadow, Harvard Medical School, Commonwealth Fusion Systems, Nature, Climate change, Patent, Robotics, Head, Wyss Institute, Applied science, Water, Judah, Bioinspiration, Growth, Climate, Hospital, Textile, Laboratory, Synthetic biology, Renewable energy, Management, Engineering, Wyss

Collaborative Fund , a New York-based venture fund, is a leading source of capital and strategic support for entrepreneurs, businesses, and protocols pushing the world forward.

Key Points: 
  • Collaborative Fund , a New York-based venture fund, is a leading source of capital and strategic support for entrepreneurs, businesses, and protocols pushing the world forward.
  • As part of the alliance, Collaborative Fund will provide $15 million to create a Laboratory for Sustainable Materials Research and Innovation at the Wyss Institute to support research into transformational technology with strong commercial potential.
  • Collaborative Fund has over a decade of experience investing in climate technology and recently launched a dedicated $200M climate fund, Collab SOS , to fuel a more sustainable economy across materials, ingredients, energy, and supply chains.
  • When it comes to climate change, there’s no time to waste,” said Sophie Bakalar, partner at Collaborative Fund.

Science for America Reports Two Promising Approaches To Fusion Power

Retrieved on: 
Friday, May 12, 2023
Ignition, Science, Climate, Field line, Education, Shorthand, National Ignition Facility, Hydrogen, Feedback, Research, Burn, Carbon, Wind, Commonwealth Fusion Systems, United Sciences of America, Pandemic, Laser, Engineering, STEM, Growth, Helium, Global Covenant of Mayors for Climate & Energy, 3D printing, Lithium, Renewable energy, SFA

CAMBRIDGE, Mass., May 12, 2023 /PRNewswire/ -- Science for America (SfA), a non-profit "solutions incubator," announced today the release of a white paper: "New Opportunities for Fusion Power." Building on recent scientific advances, the SfA white paper describes two different promising approaches for fusion power that have the potential to speed progress, decrease cost, and simplify engineering challenges and might both be tested efficiently on a single, shared "demonstration system." The white paper, developed by scientists and technologists under SfA's Climate & Energy pillar, shares the ideas freely with the aim of spurring public discussion, scientific research, and commercialization efforts to accelerate fusion as a clean, affordable, scalable power source.

Key Points: 
  • The challenge has been overcoming major scientific and engineering challenges to make practical, inexpensive fusion energy systems.
  • In one breakthrough in 2021, Commonwealth Fusion Systems showed that high-temperature superconducting tape can create the strong magnetic fields needed for compact steady-state magnetic confinement fusion.
  • "After studying a wide range of ways in which fusion might be achieved, the group shined a spotlight on two very interesting approaches."
  • The white paper, "New Opportunities for Fusion Power," has been posted to https://www.scienceforamerica.org/ to share with the scientific community.

Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights

Retrieved on: 
Tuesday, May 2, 2023
CLL, PDAC, KRAS, Insulin, Food, CRC, Diabetes, Investment, Chronic lymphocytic leukemia, Menin, DLBCL, Multiple myeloma, NPM1, Acute leukemia, CD135, Type 2 diabetes, Mutation, Cancer, NSCLC, Lung cancer, B-cell lymphoma, Acute myeloid leukemia, AML, MLL, Patient, DSM-IV codes, Colorectal cancer, Administration, Education minister, MM, FLT3, Research and development, R, Commonwealth Fusion Systems, Research, Phase, American Diabetes Association, ADA, IND, Safety, Pharmaceutical industry, Medical imaging, Osteopathic medicine in Canada, Glycated hemoglobin

We believe that none of the currently approved therapies for diabetes adequately addresses the beta cell mass and function loss.

Key Points: 
  • We believe that none of the currently approved therapies for diabetes adequately addresses the beta cell mass and function loss.
  • With its intended disease-modifying mechanism of action, BMF-219 could potentially represent a monumental shift for the treatment of patients with diabetes.
  • Reported initial clinical data in March 2023 from the first two cohorts of the Phase II portion of COVALENT-111.
  • Report initial clinical data of AML/ALL patients (including those with MLLr rearrangement and NPM1 mutations) dosed in the COVALENT-101 study in the second quarter of 2023.

Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Thursday, April 13, 2023
Exercise, Attention, Broad Street, Osteopathic medicine in Canada, Diabetes, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Telephone, Type 2 diabetes, Enterprise file synchronization and sharing, Sale, Prospectus, Patient, DSM-IV codes, Investment, Oppenheimer Holdings, Cancer, Form, FLT3, Security (finance), Commonwealth Fusion Systems, Barclays, Broadridge Financial Solutions, Pharmaceutical industry, Citigroup

The aggregate gross proceeds from the offering were $172.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Biomea.

Key Points: 
  • The aggregate gross proceeds from the offering were $172.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Biomea.
  • All shares of common stock were offered by Biomea.
  • J.P. Morgan and Citigroup acted as joint book-running managers for the offering.
  • The securities were offered by Biomea pursuant to a registration statement on Form S-3 (File No.